Anika therapeutics names board member dr. cheryl blanchard as interim ceo

Bedford, mass., feb. 12, 2020 (globe newswire) -- anika therapeutics, inc. (nasdaq: anik) today announced that dr. cheryl blanchard, a member of the company’s board of directors since august 2018, has been named interim chief executive officer, effective immediately, while the board continues its search to identify a new ceo following the recent passing of joseph darling. in connection with dr. blanchard’s appointment, the previously announced interim office of the president has been dissolved.
ANIK Ratings Summary
ANIK Quant Ranking